The role of hepatic progenitor cells in predicting response to therapy in Egyptian patients with chronic hepatitis C, genotype 4

BACKGROUND: Interferon therapy is used as a line of treatment of chronic hepatitis C virus (HCV) in several areas of the world including Egypt. OBJECTIVE: Our aim was to investigate the value of hepatic progenitor cells (HPCs) in predicting response of patients with chronic HCV, genotype 4 to pegyla...

Descripción completa

Detalles Bibliográficos
Autores principales: Helal, Thanaa El A, Radwan, Nehal A, Mahmoud, Heba A, Zaki, Ahmed ME, Ahmed, Naglaa S, Wahib, Ali AA, Aref, Ahmed M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Makerere Medical School 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531979/
https://www.ncbi.nlm.nih.gov/pubmed/31148968
http://dx.doi.org/10.4314/ahs.v19i1.14

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531979/
https://www.ncbi.nlm.nih.gov/pubmed/31148968
http://dx.doi.org/10.4314/ahs.v19i1.14

Ejemplares similares